Provided by Tiger Fintech (Singapore) Pte. Ltd.

TriSalus Life Sciences Inc.

5.50
+0.25004.76%
Volume:33.89K
Turnover:184.90K
Market Cap:208.11M
PE:-4.83
High:5.55
Open:5.22
Low:5.22
Close:5.25
Loading ...

TriSalus Life Sciences Q1 Income From Operations USD -7.329 Million

THOMSON REUTERS
·
15 May

TriSalus Life Sciences Q1 Pretax Profit USD -10.37 Million

THOMSON REUTERS
·
15 May

Press Release: TriSalus Life Sciences Reports First Quarter 2025 Results and Provides Updated 2025 Guidance

Dow Jones
·
15 May

TriSalus Life Sciences Inc expected to post a loss of 22 cents a share - Earnings Preview

Reuters
·
13 May

Press Release: TriSalus Life Sciences to Host First Quarter 2025 Financial Results Conference Call

Dow Jones
·
13 May

BRIEF-Trisalus Life Sciences Announces $22.0 Mln Private Placement

Reuters
·
30 Apr

TriSalus Life Sciences Inc - Q1 2025 Revenue Approximately $9.2 Million, 42% Growth

THOMSON REUTERS
·
30 Apr

TriSalus Life Sciences Announces $22.0 Million Private Placement Preliminary Q1 2025 Unaudited Financial Results

THOMSON REUTERS
·
30 Apr

TriSalus Life Sciences Announces $22.0 Million Private Placement Preliminary Q1 2025 Unaudited Financial Results

Business Wire
·
30 Apr

TriSalus Life Sciences files to sell 91,263 shares of common stock for holders

TIPRANKS
·
26 Apr

VAREX IMAGING (VREX) Moves 16.5% Higher: Will This Strength Last?

Zacks
·
10 Apr

TriSalus Life Sciences, Inc. (TLSI) Soars 6.6%: Is Further Upside Left in the Stock?

Zacks
·
09 Apr

TriSalus Life Sciences-Identified Errors in Timing of Stock-Based Compensation Expense, Clinical Trial Related Expenses. Use of Incorrect Assumptions

THOMSON REUTERS
·
29 Mar

TriSalus Life Sciences Inc Files Non-Timely 10-K With U.S. SEC

THOMSON REUTERS
·
29 Mar

TriSalus Life Sciences - Anticipates Annual Report Will Be Filed on or Before Fifteenth Calendar Day Following Prescribed Due Date

THOMSON REUTERS
·
29 Mar

TriSalus Life Sciences Is Maintained at Buy by Canaccord Genuity

Dow Jones
·
28 Mar

Analysts’ Top Healthcare Picks: X4 Pharmaceuticals (XFOR), TriSalus Life Sciences (TLSI)

TIPRANKS
·
28 Mar

TriSalus Life Sciences Q4 2024 GAAP EPS $(0.40) Misses $(0.32) Estimate, Sales $8.26M Beat $8.12M Estimate

Benzinga
·
27 Mar

TriSalus Life Sciences Inc - Reaffirms 2025 Guidance

THOMSON REUTERS
·
27 Mar

TriSalus Life Sciences Q4 Revenue USD 8.261 Million VS. Ibes Estimate USD 8.12 Million

THOMSON REUTERS
·
27 Mar